Description
The main objective of the Action is to gain knowledge on the role of the HOX/TALE homeodomain regulatory network in development and disease through the joint efforts of different laboratories with complementary expertises in approaches, biological processes, animal models and human diseases.
Action keywords
Homeodomain - gene expression control and cell differentiation - embryonic development - congenital malformation - tumour formation
Parties
Action Leadership Positions
| Role | Leader |
|---|---|
| Action Chair | |
| Action Vice-Chair |
Management Committee
| Country | MC Member |
|---|---|
| Belgium | |
| Denmark | |
| France | |
| France | |
| Germany | |
| Germany | |
| Hungary | |
| Israel | |
| Israel | |
| Italy | |
| Netherlands | |
| Norway | |
| Poland | |
| Portugal | |
| Spain | |
| Spain | |
| Switzerland | |
| Switzerland | |
| Türkiye | |
| United Kingdom | |
| United Kingdom |
| Country | MC Substitute |
|---|---|
| France | |
| Germany | |
| Netherlands | |
| Spain | |
| Spain | |
| United Kingdom |
COST Near Neighbour Countries
| Institution Name | MC Observer |
|---|---|
| Moscow State University - Faculty of Medicine |
COST International Partner Countries
| Institution Name | MC Observer |
|---|---|
| Columbia University Depto Biochemistry and Molecular Biophysics | |
| Cornell University Weill - Medical School | |
| University of Michigan | |
| Stanford University School of Medicine - Depto of Pathology | |
| Intitute for Research in Immunology and Cancer/IRIC?Universite de Montreal | |
| EMBL Australia, Australian Regenerative Medicine Institute, Monash University |